Peter A Schwartz, MD in W. Reading, PA - Obstetrics & Gynecology

Peter A Schwartz, MD is a Obstetrics & Gynecology physician based in W. Reading, Pennsylvania. Peter A Schwartz is licensed to practice in Pennsylvania (license number MD037199E) and his current practice location is 6th Ave And Spruce St, W. Reading, Pennsylvania. He can be reached at his office (for appointments etc.) via phone at (610) 988-8827.

NPI number for Peter A Schwartz is 1508868175 and his current mailing address is Po Box 16052, Reading, Pennsylvania. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1508868175.

Contact Information

	Peter A Schwartz, MD
	6th Ave And Spruce St, W. Reading, PA 19611
	(610) 988-8827
	(610) 988-4242

Physician's Profile

Full Name	Peter A Schwartz
Gender	Male
Speciality	Obstetrics & Gynecology
Location	6th Ave And Spruce St, W. Reading, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1508868175
Provider Enumeration Date: 08/12/2005
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Peter A Schwartz such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1508868175	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207V00000X	Obstetrics & Gynecology	MD037199E (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Peter A Schwartz is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Peter A Schwartz, MD Po Box 16052, Reading, PA 19612-6052 Ph: (610) 988-4655	Peter A Schwartz, MD 6th Ave And Spruce St, W. Reading, PA 19611 Ph: (610) 988-8827

News Archive

New experimental growth factor drug appears to prevent worsening of osteoarthritis

More than 10 percent of Americans over age 60 experience knee pain related to osteoarthritis, the most common disease of the knee joint. Osteoarthritis of the knee causes pain, activity limitation, physical disability, reduced health-related quality of life and excess mortality compared with the general population.

Snake venom toxin as a treatment for prostate cancer

This certainly sounds unusual, but Dr. Son and colleagues report on the effectiveness of the snake venom toxin (SVT) Vipera lebetina turanica in the inhibition of androgen-independent prostate cancer (AICAP) in the February 2007 issue of Molecular Cancer Therapeutics .

New research opens up potential new therapeutic targets for hard-to-treat food allergy

New research in Nature Genetics identifies a novel genetic and molecular pathway in the esophagus that causes eosinophillic esophagitis (EoE), opening up potential new therapeutic strategies for an enigmatic and hard-to-treat food allergy.

Crealta publishes review of post-hoc safety analysis completed for Krystexxa

Crealta Pharmaceuticals LLC, today announced that the Journal of Clinical Rheumatology published a comprehensive review of a post-hoc safety analysis that was completed for Krystexxa (pegloticase), including data from the two pivotal randomized Phase III trials and one open-label extension trial.

Peter A Schwartz, MD - Obstetrics & Gynecology in W. Reading, PA